EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Review of Literature to Determine Recommended Application of HPV ‐42 Molecular Testing for Digital Papillary Adenocarcinoma

Michelle Y Zhu iD, Leting Zhang, Mahyar Khazaeli

Journal of Cutaneous Pathology · 2025-09 · 52 (9) · 590-594

DOI: 10.1111/cup.14823 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 11.06.2025. Verfasst von Michelle Y Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, the State University of Ne…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Adenocarcinoma, Papillary, Papillomaviridae, Sweat Gland Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Digital Papillary Adenocarcinoma (DPA) is a rare tumor that can cause metastasis and death. It can morphologically mimic benign sweat gland tumors. In 2022, the novel association of HPV‐42 and DPA was discovered by means of DNA sequencing. In this scoping review, we aimed to systematically evaluate alternatives to HPV‐42 molecular sequencing. Of 87 articles on DPA identified in a PUBMED meta‐search, eight met the inclusion criteria. We found that DNA sequencing for HPV‐42 is most sensitive (94%). Comparable tests included HPV‐42 in situ hybridization (ISH), which had 82% sensitivity, and p16 immunohistochemistry, which had 70%–75% sensitivity. We further evaluated the performance of HPV‐42 ISH and performed a stratified analysis of HPV‐42 ISH‐negative DPA cases. There was a statistically significant difference in HPV‐42 positivity in patients younger than and older than 60 years old ( p = 0.02). We recommend HPV‐42 ISH for cases with equivocal morphology from patients aged over 60 years. Tumors with equivocal morphology from patients under the age of 60 years should be sequenced for HPV‐42. For cases with classic morphology, p16 can be used to support the diagnosis, but molecular testing for HPV‐42 is unnecessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsAdenocarcinoma, PapillaryPapillomaviridaeSweat Gland NeoplasmsHumansIn Situ HybridizationFemaleImmunohistochemistryMiddle AgedMale

Stichwörter der Autor:innen

carcinoma skin appendagedigital papillary adenocarcinomaneoplasms adnexal and skin appendagepapillomavirus infections

Autor:innen und Institutionen

  • Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, the State University of New York, Buffalo, New York, USA.
  • University of Delaware, Newmark, Delaware, USA.
  • Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Michelle Y Zhu

Zitieren

APA

Zhu, M. Y., Zhang, L., & Khazaeli, M. (2025). Review of Literature to Determine Recommended Application of HPV ‐42 Molecular Testing for Digital Papillary Adenocarcinoma. Journal of Cutaneous Pathology, 52(9), 590-594. https://doi.org/10.1111/cup.14823

Vancouver

Zhu MY, Zhang L, Khazaeli M. Review of Literature to Determine Recommended Application of HPV ‐42 Molecular Testing for Digital Papillary Adenocarcinoma. Journal of Cutaneous Pathology. 2025;52(9):590-594. doi:10.1111/cup.14823

BibTeX
@article{Zhu2025,
  author = {Zhu, Michelle Y and Zhang, Leting and Khazaeli, Mahyar},
  title = {Review of Literature to Determine Recommended Application of HPV ‐42 Molecular Testing for Digital Papillary Adenocarcinoma},
  journal = {Journal of Cutaneous Pathology},
  year = {2025},
  volume = {52},
  number = {9},
  pages = {590--594},
  doi = {10.1111/cup.14823}
}
Kostenlos starten →